Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy: Long-term outcome of the LPA 99 multicenter study by the PETHEMA Group

1. Sanz, M.A.
2. Montesinos, P.
3. Vellenga, E.
4. Rayón, C.
5. De La Serna, J.
6. Parody, R.
7. Bergua, J.M.
8. León, A.
9. Negri, S.
10. González, M.
11. Rivas, C.
12. Esteve, J.
13. Milone, G.
14. González, J.D.
15. Amutio, E.
16. Brunet, S.
17. García-Laraña, J.
18. Colomer, D.
19. Calasanz, M.J.
20. Chillón, C.
21. Barragán, E.
22. Bolufer, P.
23. Lowenberg, B.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1182/BLOOD-2008-05-159632 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

•